Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' EQUITY - Changes in Shareholders' Equity (Details)

v3.22.1
SHAREHOLDERS' EQUITY - Changes in Shareholders' Equity (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Balance $ 62,265 $ 35,886 $ 26,099 $ 7,365 $ 7,365
Share-based compensation   530 2,701 2,305  
Reclassification of derivative liability for authorized share deficiency   (3,591)   (3,591)  
Fair value of warrants issued to consultants for services 850 2   8  
Net Loss (11,208) (3,695) (31,637) (14,412) (20,900)
Balance 51,907 29,132 51,907 29,132 26,099
Common Stock          
Balance $ 16 $ 8 $ 8 $ 6 $ 6
Balance (in shares) 15,556 8,352 8,352 5,867 5,867
Balance $ 16 $ 8 $ 16 $ 8 $ 8
Balance (in shares) 15,556 8,352 15,556 8,352 8,352
Additional Paid-in Capital          
Balance $ 250,816 $ 193,831 $ 194,229 $ 154,595 $ 154,595
Share-based compensation   530 2,701 2,305  
Reclassification of derivative liability for authorized share deficiency   (3,591)   (3,591)  
Fair value of warrants issued to consultants for services 850 2   8  
Balance 251,666 190,772 251,666 190,772 194,229
Accumulated Deficit          
Balance (188,567) (157,953) (168,138) (147,236) (147,236)
Net Loss (11,208) (3,695) (31,637) (14,412)  
Balance $ (199,775) $ (161,648) $ (199,775) $ (161,648) $ (168,138)